Abstract:Irritable bowel syndrome (IBS) is the most prevalent functional disease of the gastrointestinal tract. This highly prevalent condition is best diagnosed by assessing the constellation of symptoms with which patients present to their physicians. Because some critics have previously questioned whether irritable bowel syndrome and other functional gastrointestinal disorders truly exist because they do not have defining structural features, the Rome Foundation fostered the use of symptom-based criteria for universal use. In most cases treatment is reduced to symptomatic therapy because a lot of unknown in pathogenesis by irritable bowel syndrome. Irritable bowel syndrome leads to decrease of quality of life of the patients and could be one of the reasons of patients' disability. Food is believed by patients promotes symptoms and the diet or avoiding specific food can reduce symptoms. Possible role of different food and microbiota in the pathophysiology of irritable bowel syndrome, as well as the data from randomized, controlled clinical trials dedicated to the effects of diet in irritable bowel syndrome are summarized and discussed in this review. The efficacy of the diet, enriched by fiber, prebiotics, probiotics, peppermint oil, curcumin and vitamin B6 in irritable bowel syndrome patients was shown in numerous studies. In some studies restriction in consumption of fermented carbohydrates, coffee and alcohol, as well as diet with elimination IgG-sensed food was also shown to be effective in irritable bowel syndrome. Food intolerances, defined as non-toxic non-immune adverse reactions to food, include reactions to bioactive chemicals in foods and metabolic reactions to poorly absorbed dietary carbohydrates. New dietary approaches like polyunsaturated fatty acids intake correction and the low tryptophan intake are discussed.

Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview

Irritable bowel syndrome: recent and novel therapeutic approaches

[The proven and the new in the pharmacotherapy of irritable bowel syndrome]

Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches

Current and novel therapeutic options for irritable bowel syndrome management

Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time

New drugs in the management of the irritable bowel syndrome

Pharmacological management of irritable bowel syndrome

Irritable bowel syndrome - from etiopathogenesis to therapy

Phytochemistry, ethnopharmacology and novel formulations based approaches for the treatment of irritable bowel syndrome: a comprehensive review

Irritable Bowel Syndrome: A Review and Update

Irritable bowel syndrome: diagnosis and management

New developments in the treatment of irritable bowel syndrome

The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to Management

[Contemporary dietotherapy of the irritable bowel syndrome]

Psychotherapeutic Interventions in Irritable Bowel Syndrome

Progress in the new drugs for the treatment of irritable bowel syndrome

Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome

Potential neuro-immune therapeutic targets in irritable bowel syndrome

Current Recommendations and Evidence

Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options